Modelos tumorais 2D e 3D para a avaliação de fármacos

Detalhes bibliográficos
Autor(a) principal: Barros, Andreia Sofia de Sousa
Data de Publicação: 2018
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.6/9772
Resumo: Drug combination emerged as a solution for the treatment of cancer, once this therapeutic approach allows to surpass the drug resistance of cancer cells and, simultaneously, eradicate the tumor. The assessment of drug-combination for pancreatic cancer treatment is usually performed in 2D cell cultures. However, these models are unable to mimic the drug resistance profiles found in pancreatic cancer. Thus, they may overestimate the therapeutic potential of the drug combination, leading to poor therapeutic performance in in vivo assays. Therefore, 3D culture models, especially spheroids, appear as a promising method for screening anticancer drugs, since they are able to mimic the structural and functional features of solid tumors. In the present study, the therapeutic effect and the synergistic potential of a particular combination of drugs in 2D and 3D cell cultures were analyzed and compared for the first time. In this way, the effect of the combination of Doxorubicin:Resveratrol (DOX:RES) (at molar ratios ranging from 5: 1 to 1: 5), in the viability of the pancreatic cancer cell line, PANC-1, was studied. The results showed that the viability of PANC-1 cells was more affected when the DOX:RES combinations contained a higher content of RES (molar ratios of 1:2 to 1:5). These results can be explained, by the ability of RES to reduce the efflux of DOX, mediated by P-glycoprotein (P-gp). Furthermore, these data also revealed that the synergistic effect of the DOX:RES combination was different in both 2D and 3D cell cultures. In fact, although 1:4 and 1:5 DOX: RES ratios were synergistic for these types of cell cultures, their values Combination Index (CI) were lower (more synergistic) in 2D cultures, when compared to spheroids. Overall, the results obtained revealed that the combination DOX:RES is promising approach for the treatment of pancreatic cancer and corroborate the need to perform drug screening.
id RCAP_fbf74dc5eac14bb330c51b28b1195666
oai_identifier_str oai:ubibliorum.ubi.pt:10400.6/9772
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Modelos tumorais 2D e 3D para a avaliação de fármacosCancro do PâncreasCulturas Celulares 2dDoxorrubicinaEsferóidesResveratrolDomínio/Área Científica::Ciências Médicas::Ciências BiomédicasDrug combination emerged as a solution for the treatment of cancer, once this therapeutic approach allows to surpass the drug resistance of cancer cells and, simultaneously, eradicate the tumor. The assessment of drug-combination for pancreatic cancer treatment is usually performed in 2D cell cultures. However, these models are unable to mimic the drug resistance profiles found in pancreatic cancer. Thus, they may overestimate the therapeutic potential of the drug combination, leading to poor therapeutic performance in in vivo assays. Therefore, 3D culture models, especially spheroids, appear as a promising method for screening anticancer drugs, since they are able to mimic the structural and functional features of solid tumors. In the present study, the therapeutic effect and the synergistic potential of a particular combination of drugs in 2D and 3D cell cultures were analyzed and compared for the first time. In this way, the effect of the combination of Doxorubicin:Resveratrol (DOX:RES) (at molar ratios ranging from 5: 1 to 1: 5), in the viability of the pancreatic cancer cell line, PANC-1, was studied. The results showed that the viability of PANC-1 cells was more affected when the DOX:RES combinations contained a higher content of RES (molar ratios of 1:2 to 1:5). These results can be explained, by the ability of RES to reduce the efflux of DOX, mediated by P-glycoprotein (P-gp). Furthermore, these data also revealed that the synergistic effect of the DOX:RES combination was different in both 2D and 3D cell cultures. In fact, although 1:4 and 1:5 DOX: RES ratios were synergistic for these types of cell cultures, their values Combination Index (CI) were lower (more synergistic) in 2D cultures, when compared to spheroids. Overall, the results obtained revealed that the combination DOX:RES is promising approach for the treatment of pancreatic cancer and corroborate the need to perform drug screening.A combinação de fármacos constitui uma abordagem terapêutica que tem sido usada no tratamento do cancro, uma vez que permite ultrapassar a resistência a fármacos das células cancerígenas e, simultaneamente, erradicar o tumor. A avaliação da combinação de fármacos é, habitualmente, realizada em modelos de cultura 2D. No entanto, estes modelos são incapazes de representar o perfil de resistência a fármacos que as células do cancro do pâncreas exibem. Deste modo, estes modelos podem sobrestimar o potencial terapêutico da combinação de fármacos, levando a um fraco desempenho terapêutico destes fármacos, nos ensaios in vivo. Recentemente, os modelos de cultura 3D, nomeadamente os esferóides, surgiram como plataformas promissoras para avaliação de combinação de fármacos anticancerígenos, uma vez que mimetizam eficazmente os mecanismos dos tumores in vivo. No presente estudo, analisou-se e comparou-se, pela primeira vez, o efeito terapêutico e o potencial sinergético da combinação de fármacos em culturas celulares 2D e 3D. Para tal, estudou-se o efeito da combinação de Doxorrubicina:Resveratrol (DOX:RES), com diferente rácios molares de 5:1 até 1:5, na viabilidade de células cancerígenas do pâncreas (PANC-1). Os resultados obtidos mostraram que a viabilidade das células PANC-1 foi mais afetada quando as combinações DOX:RES continham maior concentração de RES (rácios molares de 1:2 a 1:5). Estes resultados podem ser explicados pelo facto do RES ter capacidade de reduzir o efluxo da DOX para o exterior da célula, mediado pela glicoproteína-P (P-gp). Os dados revelaram também que o efeito sinérgico da combinação DOX:RES em culturas 2D e 3D foi diferente. De facto, apesar das proporções 1:4 e 1:5 DOX:RES apresentarem ambas um efeito sinérgico para os dois tipos de culturas, os seus valores de Índice de Combinação (CI) foram inferiores (mais sinérgicos) nas culturas 2D. Deste modo, os resultados obtidos revelaram que a combinação DOX:RES é uma abordagem promissora para o tratamento do cancro do pâncreas e corroboram a necessidade de avaliar a combinação de fármacos em culturas 3D.Correia, Ilídio Joaquim SobreiraCosta, Elisabete Cristina da RochauBibliorumBarros, Andreia Sofia de Sousa2021-06-20T00:30:15Z2018-07-202018-06-202018-07-20T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.6/9772TID:202353982enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-12-15T09:51:01Zoai:ubibliorum.ubi.pt:10400.6/9772Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:49:51.404437Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Modelos tumorais 2D e 3D para a avaliação de fármacos
title Modelos tumorais 2D e 3D para a avaliação de fármacos
spellingShingle Modelos tumorais 2D e 3D para a avaliação de fármacos
Barros, Andreia Sofia de Sousa
Cancro do Pâncreas
Culturas Celulares 2d
Doxorrubicina
Esferóides
Resveratrol
Domínio/Área Científica::Ciências Médicas::Ciências Biomédicas
title_short Modelos tumorais 2D e 3D para a avaliação de fármacos
title_full Modelos tumorais 2D e 3D para a avaliação de fármacos
title_fullStr Modelos tumorais 2D e 3D para a avaliação de fármacos
title_full_unstemmed Modelos tumorais 2D e 3D para a avaliação de fármacos
title_sort Modelos tumorais 2D e 3D para a avaliação de fármacos
author Barros, Andreia Sofia de Sousa
author_facet Barros, Andreia Sofia de Sousa
author_role author
dc.contributor.none.fl_str_mv Correia, Ilídio Joaquim Sobreira
Costa, Elisabete Cristina da Rocha
uBibliorum
dc.contributor.author.fl_str_mv Barros, Andreia Sofia de Sousa
dc.subject.por.fl_str_mv Cancro do Pâncreas
Culturas Celulares 2d
Doxorrubicina
Esferóides
Resveratrol
Domínio/Área Científica::Ciências Médicas::Ciências Biomédicas
topic Cancro do Pâncreas
Culturas Celulares 2d
Doxorrubicina
Esferóides
Resveratrol
Domínio/Área Científica::Ciências Médicas::Ciências Biomédicas
description Drug combination emerged as a solution for the treatment of cancer, once this therapeutic approach allows to surpass the drug resistance of cancer cells and, simultaneously, eradicate the tumor. The assessment of drug-combination for pancreatic cancer treatment is usually performed in 2D cell cultures. However, these models are unable to mimic the drug resistance profiles found in pancreatic cancer. Thus, they may overestimate the therapeutic potential of the drug combination, leading to poor therapeutic performance in in vivo assays. Therefore, 3D culture models, especially spheroids, appear as a promising method for screening anticancer drugs, since they are able to mimic the structural and functional features of solid tumors. In the present study, the therapeutic effect and the synergistic potential of a particular combination of drugs in 2D and 3D cell cultures were analyzed and compared for the first time. In this way, the effect of the combination of Doxorubicin:Resveratrol (DOX:RES) (at molar ratios ranging from 5: 1 to 1: 5), in the viability of the pancreatic cancer cell line, PANC-1, was studied. The results showed that the viability of PANC-1 cells was more affected when the DOX:RES combinations contained a higher content of RES (molar ratios of 1:2 to 1:5). These results can be explained, by the ability of RES to reduce the efflux of DOX, mediated by P-glycoprotein (P-gp). Furthermore, these data also revealed that the synergistic effect of the DOX:RES combination was different in both 2D and 3D cell cultures. In fact, although 1:4 and 1:5 DOX: RES ratios were synergistic for these types of cell cultures, their values Combination Index (CI) were lower (more synergistic) in 2D cultures, when compared to spheroids. Overall, the results obtained revealed that the combination DOX:RES is promising approach for the treatment of pancreatic cancer and corroborate the need to perform drug screening.
publishDate 2018
dc.date.none.fl_str_mv 2018-07-20
2018-06-20
2018-07-20T00:00:00Z
2021-06-20T00:30:15Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.6/9772
TID:202353982
url http://hdl.handle.net/10400.6/9772
identifier_str_mv TID:202353982
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136389706547200